Bend, OR, United States of America

David Kenneth Lyon

This inventor holds 1 USPTO granted patent. Top assignee: Bend Research, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Kenneth Lyon. Retrieved from https://idiyas.com/inventor/david-kenneth-lyon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Kenneth Lyon: Innovator in Pharmaceutical Compositions

Introduction

David Kenneth Lyon is a notable inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in enhancing the performance of low-solubility drugs. His innovative approach has led to the development of compositions that improve drug concentrations in various environments.

Latest Patents

David Kenneth Lyon holds 1 patent for his work titled "Pharmaceutical compositions with enhanced performance." This patent discloses pharmaceutical compositions that combine low-solubility drugs with lower alkanoate-, phthalate-, and trimellitate esters of hydroxypropyl methyl cellulose, as well as lower alkanoate- and succinate esters of cellulose and methyl cellulose. These compositions are designed to provide enhanced concentrations of the drug in a use environment.

Career Highlights

Lyon is associated with Bend Research, Inc., where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, David Kenneth Lyon has collaborated with notable colleagues, including Walter Christian Babcock and Dwayne Thomas Friesen. These partnerships have contributed to the advancement of research and development in pharmaceutical compositions.

Conclusion

David Kenneth Lyon's contributions to pharmaceutical innovations demonstrate his commitment to enhancing drug performance. His work continues to impact the field positively, paving the way for future advancements in pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…